Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Jose R. Sotolongo, Jr., M.D., Mount Sinai Medical Center: On July 3, 1995, ORI found that Jose R. Sotolongo, Jr., M.D., formerly of Mount Sinai Medical Center in New York, committed scientific misconduct by falsifying research involving guanabenz treatment of spinal cord injured cats presented in a Public Health Service (PHS) grant application. Dr. Sotolongo has entered into a Voluntary Exclusion Agreement with ORI in which he has accepted ORI\'s finding and has agreed to exclude himself voluntarily, for the three (3) year period beginning July 3, 1995, from: (1) Applying for or receiving any Federal grant or contract funds; and, (2) Serving in any advisory capacity to the PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. The above voluntary exclusion, however, shall not apply to Dr. Sotolongo\'s future training or practice of clinical medicine as a licensed practitioner unless that practice involves research or research training. No scientific publications were required to be corrected as part of this Agreement.
